Gavi, the Vaccine Alliance-"la Caixa" Foundation: the Alliance for Childhood Vaccination Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

la Caixa Foundation committed €15 million to Gavi between 2008 and 2012 (Exhibit 1).
Gavi Matching Fund: Bill & Melinda Gates Foundation pledged to match corporate and individual contributions dollar-for-dollar (Paragraph 4).
The Alliance for Childhood Vaccination (ACV) raised approximately €18.4 million by 2013, with 250,000 donors participating (Exhibit 2).
Cost per child vaccinated: Gavi estimates roughly $20–$25 per child for full immunization (Paragraph 7).

Operational Facts

la Caixa operates primarily in Spain; Gavi operates globally in low-income countries (Paragraph 2).
ACV mechanism: la Caixa collects funds via payroll giving, corporate social responsibility (CSR) programs, and direct public campaigns (Paragraph 5).
Governance: la Caixa maintains internal control over marketing/fundraising; Gavi handles technical vaccine procurement and delivery (Paragraph 9).

Stakeholder Positions

la Caixa Foundation: Seeks to maintain high donor engagement and brand alignment with health outcomes.
Gavi: Seeks predictable, long-term funding to secure vaccine supply chains.
Public Donors: Motivated by direct impact transparency (e.g., seeing how many children were vaccinated).

Information Gaps

Specific overhead/administrative costs incurred by la Caixa for the ACV campaign are not disclosed.
Long-term attrition rates of individual donors after the initial five-year cycle remain unquantified.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How can la Caixa and Gavi transition from a time-bound partnership to a sustainable, scalable model that maintains donor growth without exhausting the Spanish donor base?

Structural Analysis

Value Chain: The partnership bridges the gap between European wealth and global public health. The constraint is not the demand for vaccines, but the sustainability of the fundraising funnel in a single geographic market (Spain).
Donor Lifecycle: Donor fatigue is the primary threat. The ACV model relies on high-touch marketing; shifting to a low-touch, digital-first model is required to maintain margins.

Strategic Options

Option 1: Geographic Expansion. Leverage the ACV model into other European markets where la Caixa has a presence. Trade-off: High setup costs, requires local regulatory compliance for fundraising.
Option 2: Product Diversification. Pivot from childhood vaccination to broader health initiatives (e.g., maternal health). Trade-off: Dilutes the clear, singular impact narrative that drove initial success.
Option 3: Digital Integration. Maintain the Spanish base but shift to a recurring monthly subscription model for individual donors. Trade-off: Requires significant investment in CRM technology and data analytics.

Preliminary Recommendation

Adopt Option 3. It maximizes the lifetime value of existing donors while minimizing the operational complexity of entering new, fragmented European markets.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Month 1–3: Audit current donor database to identify high-propensity recurring donors.
Month 4–6: Develop and pilot a digital subscription portal integrated with existing la Caixa banking infrastructure.
Month 7–9: Roll out automated, impact-based reporting (e.g., email updates showing direct vaccination progress to subscribers).

Key Constraints

Data Privacy: GDPR and Spanish data protection laws limit aggressive retargeting.
Donor Fatigue: The economic environment in Spain remains sensitive; high-frequency solicitations will increase churn.

Risk-Adjusted Implementation

Build a 15% contingency budget for digital acquisition costs. If subscription conversion rates fall below 5% in the first quarter, revert to the baseline seasonal campaign model.

4. Executive Review and BLUF (Executive Critic)

BLUF

The ACV partnership is a success in fundraising but a liability in scalability. Relying on a single market (Spain) creates a ceiling for growth. The recommended transition to a subscription model is necessary but insufficient. The partnership must pivot to a B2B-led model, targeting corporate payroll giving across the broader European footprint of la Caixa. This shifts the burden of acquisition from the foundation to the employer. If the foundation does not move toward this institutionalized model, the current gains will erode as the donor base ages and personal disposable income in Spain remains stagnant.

Dangerous Assumption

The analysis assumes that the existing Spanish donor base will maintain interest in a subscription model. This ignores the reality of donor churn in non-profit health sectors, which often exceeds 30% annually.

Unaddressed Risks

Currency/Economic Risk: A downturn in the Spanish banking sector directly impacts the foundation’s ability to subsidize the campaign's administrative costs.
Reputational Contagion: Any negative public perception of the banking partner (la Caixa) will immediately halt donations to the vaccine alliance.

Unconsidered Alternative

A B2B-centric model: Instead of individual donor acquisition, treat the vaccine alliance as a premium CSR service for mid-sized European corporations. This provides institutional stability and higher per-transaction volume.